GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » EV-to-FCF

APT Medical (SHSE:688617) EV-to-FCF : 332.14 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is APT Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, APT Medical's Enterprise Value is ¥34,697 Mil. APT Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥104 Mil. Therefore, APT Medical's EV-to-FCF for today is 332.14.

The historical rank and industry rank for APT Medical's EV-to-FCF or its related term are showing as below:

SHSE:688617' s EV-to-FCF Range Over the Past 10 Years
Min: 46.45   Med: 105.47   Max: 1274.31
Current: 328.35

During the past 7 years, the highest EV-to-FCF of APT Medical was 1274.31. The lowest was 46.45. And the median was 105.47.

SHSE:688617's EV-to-FCF is ranked worse than
96.52% of 374 companies
in the Medical Devices & Instruments industry
Industry Median: 28.73 vs SHSE:688617: 328.35

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), APT Medical's stock price is ¥364.96. APT Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥6.765. Therefore, APT Medical's PE Ratio (TTM) for today is 53.95.


APT Medical EV-to-FCF Historical Data

The historical data trend for APT Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical EV-to-FCF Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - 1,249.37 86.56 50.89

APT Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.76 50.89 70.68 253.19 373.07

Competitive Comparison of APT Medical's EV-to-FCF

For the Medical Devices subindustry, APT Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


APT Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where APT Medical's EV-to-FCF falls into.



APT Medical EV-to-FCF Calculation

APT Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=34697.007/104.464
=332.14

APT Medical's current Enterprise Value is ¥34,697 Mil.
APT Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥104 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


APT Medical  (SHSE:688617) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

APT Medical's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=364.96/6.765
=53.95

APT Medical's share price for today is ¥364.96.
APT Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.765.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


APT Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of APT Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


APT Medical Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Executives
Dai Zhen Hua Directors, senior managers
Cheng Zheng Hui Directors, senior managers
Zhang Yong Core technical personnel
Liu Fang Yuan senior management
Wang Wei senior management
Senior management, core technical personnel
Xu Yi Qing Directors, senior managers
Han Yong Gui Senior management, core technical personnel

APT Medical Headlines

No Headlines